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Abstract
Background: ‘Non-compliant’ individuals in opioid maintenance treatment, OMT, are often met with tight control
regimes to reduce the risk of ‘diversion’, which may lead to harm or death among persons outside of OMT. This
article explores reported practices of, and motivations for, diversion of methadone and buprenorphine, in a group
of imprisoned individuals in OMT.
Findings: 28 in-depths interviews were conducted among 12 OMT-enrolled, imprisoned individuals, most of whom
were remand prisoners. All had experienced tight control regimes prior to imprisonment due to varying degrees of
‘non-compliance’ and illicit drug use during treatment. Their acquired norm of sharing with others in a drug using
community was maintained when entering OMT. Giving one’s prescription opioids to an individual in withdrawal
was indeed seen as an act of helping, something that takes on particular significance for couples in which only one
partner is included in OMT and the other is using illicit heroin. Individuals enrolled in OMT might thus be trapped
between practicing norms of helping and sharing and adhering to treatment regulations. ’Diversion’, as this term is
conventionally used, is not typically understood as practices of giving and helping, but may nevertheless be
perceived as such by those who undertake them.
Conclusions: As we see it, the need to sustain oneself as a decent person in one’s own eyes and those of others
through practices such as sharing and helping should be recognized. Treatment providers should consider
including couples in which both individuals are motivated for starting OMT.
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Background
‘Non-compliant’ individuals in opioid maintenance
treatment, OMT, are often met with tight control re-
gimes [1-3] to reduce the risk of ‘diversion’ and thereby
prevent harm or death among persons outside of the
treatment program [4]. Reported motivations among
persons who divert OMT medications consist of selling
to support one’s own economy [5], as well as giving to
friends and acquaintances as a social resource [6,7].
Thus, a thorough understanding of the realities of the
people such measures are meant to meet needs to be
internal to the planning, development and implementa-
tion of treatment regulations in OMT. This article,
which is based on a study that explored motivations for
criminal activity, focuses on reported practices of and
motivations for methadone and buprenorphine diversion
in a group of imprisoned, OMT-enrolled individuals.
Context
The Norwegian OMT programme started in 1998 as a
restrictive and high-threshold treatment system [8]. In
2004, individuals in OMT obtained rights as patients.
The 2010 national guidelines focus on individual re-
habilitation, patient rights and harm reduction, at per-
sonal and societal levels. Individuals lacking or with
positive urine tests may be subject to daily, supervised
intake of OMT medication and may be limited in their
medication choice. The guidelines emphasize the import-
ance of social network mapping, with a focus on possible
substance use. Though it is not an explicit goal, couples
can be in treatment together [9].
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Sample and method
The findings presented in this paper are derived from a
qualitative study that formed part of a larger crime study
[10-12]. All together, 28 semi-structured interviews were
conducted with twelve imprisoned individuals between
22 and 50 years of age; nine men and three women. The
majority of these participants were remand prisoners
and ten were formerly convicted of violent crime. Time
previously served in prison ranged 1.5 to 20 years. All
interviews were conducted in prison. For cross-case
analysis and to validate findings, repeat interviews were
performed for all but two participants who were re-
leased from the remand wing on short notice. Among
the interview topics explored were: experiences with
OMT, diversion of OMT-medications, norm systems,
health issues, motivations for and understandings of
criminal activity during OMT and life situations before
imprisonment. The interviews were audio recorded and
transcribed verbatim. The exploratory, thematic analysis
was carried out by the first and last authors, with a re-
flexive and interactive approach throughout the entire
research process.
Ethics
Ethical approval was obtained from the Norwegian
Regional Committee for Medical Research Ethics, the
Norwegian Social Science Data Services and the
Norwegian Correctional Service Region East. Verbal
and written consent procedures were carried out with all
participants. Emphasis was placed on ensuring anonymity
throughout the publication process.
Findings
Those who participated in this study had all been
convicted of theft and drug-related crimes. The majority
were also convicted of violence towards others, thus
exhibiting what is often regarded as ‘anti-social’ behavior
[13-15]. But, so-called ‘anti-social’ behavior can hardly
be seen as the only form of sociality demonstrated. Prac-
tices of and attitudes towards helping and giving were
hence among the phenomena explored in our endeavor
to achieve a fuller account of the social lives of these
imprisoned, opioid-dependent persons.
While only one of the project participants reported
regularly selling or exchanging his methadone for heroin,
several individuals had indeed developed strategies to pre-
vent themselves from selling their prescription opioids.
Among these were: avoiding potential buyers by taking al-
ternatives routes to and arriving late at the pharmacy,
maintaining a secretive status as OMT-patients and asking
family members for help with monetary problems. Those
who gave methadone and buprenorphine to friends and
acquaintances regarded doing so as ‘helping’ and ‘giving’,
as opposed to selling or exchanging. They all experienced
tightly-controlled opioid prescription regimes outside of
prison as a hindrance to ‘helping’ others in need. ‘Helping’
had been possible, however, and especially for those who
received one take-home dose on weekends.
In what follows, we present some cases. We begin with
Hugo and Ståle, both of whom had unstable housing
and lived in homeless shelters prior to and during OMT,
hence experiencing daily contact with friends and ac-
quaintances in active heroin use. Hugo was among those
who appreciated being able to help others. He explained
that, due to daily supervised intake of buprenorphine, he
had only been able to help a close friend a few times
while enrolled in OMT. He contrasted this with a two-
year period prior to OMT when he had used illegal
buprenorphine on a daily basis. At that time, he had
access to large amounts of buprenorphine, making it
possible to regularly give it to a friend in withdrawal.
Hugo did not want anything in return. Ståle, who occa-
sionally gave his stockpiled methadone to a friend in
withdrawal was also clear about the fact that he did not
expect anything in return. It should be noted that such
acts of ‘helping’ take on particular significance for cou-
ples. Erik, for example, lived together with a woman
addicted to heroin for many years prior to OMT. He
explained that they were then mutually responsible for
obtaining heroin:
One day one will manage to get some [heroin], the
other day the other will manage to get some, or we
will get some together. Or we don't get any. You don’t
always have some.
While Erik accepted that he could not always obtain
heroin, it was impossible for Mona to do so. She strongly
feared withdrawal and said that she needed a steady in-
come to ensure that she could always buy the heroin she
needed. When she became involved in a relationship with
a heroin-dependent man, higher income was needed. Even
if he contributed, Mona did not have the security that she
needed and explained that her choice was then between 3
“hells”: selling drugs, committing property crime or selling
sex. She chose the latter because it gave her more control.
Her male partner was included in OMT due to his wors-
ening health status. He received a daily, supervised dose of
methadone. Hence, he could not share his methadone
when she was in withdrawal. They lived together, he in
OMT and she on heroin. She continued to sell sex and
regularly experienced violence and humiliation. This was a
painful situation for both.
In contrast to Mona and her partner, Simon was
among those who found a situation in which only one
partner was enrolled in OMT to be an impossible one.
Before entering treatment, he had had a partner who
was addicted to heroin and was clear about his opinion
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that a relationship in which one partner is in treatment
and one dependent on illegal drugs involves unsolvable
and unbearable moral dilemmas:
Then you have to come up with ways [to give away
your medication] to help your girlfriend if she is
having a bad day. You can't just leave your girlfriend
in withdrawal if you can help. So you're off to hell of a
bad start if you can't both get help [treatment],
together.
Discussion
The study participants had all committed serious crimes
and reported criminal activity during OMT. They were
all imprisoned at the time of the interviews, which may
have influenced their decisions to share particular expe-
riences and events and perhaps also their understand-
ings of and retrospective reflections on these events and
their consequences [16]. All participants were seen as
‘non-compliant’ by treatment providers and were subject
to daily, supervised intake of their opioid prescriptions
outside of prison. Nonetheless, these facts should not be
taken to imply that they were exclusively ‘anti-social’
[13-15]. Social dimensions are often unaccounted for
when encoding ‘deviant behavior’ [17,18] and it seems
relevant to acknowledge and explore the participants’
practices of sociality, such as drug giving and sharing.
The moral economy of sharing in drug cultures is well
documented by the ethnographic work of Bourgois [19,20]
and the act of giving heroin in ‘a community of addicted
bodies’ is based on a moral value of reciprocity [21]: “It is
considered unethical to leave a person stranded when he
or she is dopesick , unless one is openly feuding with that
person”. We suggest that such communities are also
communities of ‘knowers’ – namely, people who pos-
sess corporeal knowledge of withdrawal and are thus,
quite literally, able to understand the corporeal condi-
tion of another human being in that state. Importantly,
the act of giving to a friend in withdrawal with known
tolerance for opioids may have a lower harm potential
than that of selling to unknown and potentially opioid-
naive persons [4].
When a heroin-dependent individual is included in
OMT, he or she might struggle to navigate norms of
different social systems: the treatment system with its
external control measures and possibilities for ‘sanctions’
for what is perceived as ‘diversion’ and drug using com-
munities with their values of civil and informal execution
of what is perceived as ‘sharing and giving’. The logics
upon which these systems are based – namely, ‘harm’ and
‘helping’, respectively – might work against each other.
OMT enrollment can hence place someone in a position
in which he or she violates his or her norms of helping
and sharing in order to follow treatment regulations.
Diversion’, as this term is conventionally interpreted by
clinicians, is not typically understood as practices of giving
and helping. These practices may nevertheless be per-
ceived as such by those who undertake them. For those
who participated in this study, it was not as though norms
for interpersonal relations maintained while using illegal
drugs could be nullified when entering treatment. As we
see it, the need to sustain oneself as a decent person in
one’s own eyes and those of others should be recognized.
Thus, the ‘positive’ interpersonal skills and practices of
OMT patients could perhaps be further explored as pos-
sible resources throughout the clinical encounter and re-
habilitation process. Further, clinicians should encourage
and support strategies developed by individuals in OMT
to avoid diversion of their opioid prescriptions, such as
changing from one dispensing pharmacy to another in an
effort to avoid potential buyers in certain areas. Finally,
treatment providers should focus on the patients’ social
lives and indeed consider including couples if both indi-
viduals are motivated for starting OMT.
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